TrialLancet (London, England)2017

Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.

Celina Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.